Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

PYY3-36 as an anti-obesity drug target.

PYY3-36 as an anti-obesity drug target. Obes Rev. 2005 Nov; 6(4):307-22.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.